Search Results for: CLU

56 interactions involving CLU - clusterin found:

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel ADGRF4 adhesion G protein-coupled receptor F4
Novel CBR3 carbonyl reductase 3
  • Phase I - Functionalization of compounds
Novel DUSP13 dual specificity phosphatase 13
Novel GEMIN7 gem nuclear organelle associated protein 7
  • snRNP Assembly
Novel KRT12 keratin 12
  • Keratinization
  • Formation of the cornified envelope
  • Griseofulvin
  • Anthralin
  • Meesmann corneal dystrophy
Novel NAT2 N-acetyltransferase 2
  • Acetylation
APP amyloid beta precursor protein
  • Platelet degranulation
  • ECM proteoglycans
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Lysosome Vesicle Biogenesis
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • The NLRP3 inflammasome
  • Advanced glycosylation endproduct receptor signaling
  • Advanced glycosylation endproduct receptor signaling
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • Post-translational protein phosphorylation
  • TRAF6 mediated NF-kB activation
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Purinergic signaling in leishmaniasis infection
  • Amyloid fiber formation
  • Deferoxamine
  • Aluminium
  • Zinc
  • L-methionine (R)-S-oxide
  • Resveratrol
  • Tromethamine
  • Phenserine
  • Tetrathiomolybdate
  • CAD106
  • Mito-4509
  • Edonerpic
  • Dimercaprol
  • Copper
  • Florbetaben (18F)
  • Florbetapir (18F)
  • Flutemetamol (18F)
  • Zinc acetate
  • Aluminium phosphate
  • Aluminum acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Alzheimer's disease (AD)
BAG6 BAG cochaperone 6
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
C7 complement C7
  • Terminal pathway of complement
  • Regulation of Complement cascade
  • Late complement pathway defects, including the following seven diseases: C5 deficiency; C6 deficiency; C7 deficiency; C8 alpha-chain deficiency; C8 beta-chain deficiency; C8 gamma-chain deficiency; C9 deficiency
C8B complement C8 beta chain
  • Terminal pathway of complement
  • Regulation of Complement cascade
  • Zinc
  • Copper
  • Zinc acetate
  • Late complement pathway defects, including the following seven diseases: C5 deficiency; C6 deficiency; C7 deficiency; C8 alpha-chain deficiency; C8 beta-chain deficiency; C8 gamma-chain deficiency; C9 deficiency
C9 complement C9
  • Terminal pathway of complement
  • Regulation of Complement cascade
  • Copper
  • Late complement pathway defects, including the following seven diseases: C5 deficiency; C6 deficiency; C7 deficiency; C8 alpha-chain deficiency; C8 beta-chain deficiency; C8 gamma-chain deficiency; C9 deficiency
CBY1 chibby family member 1, beta catenin antagonist
  • Deactivation of the beta-catenin transactivating complex
CD209 CD209 molecule
  • CD209 (DC-SIGN) signaling
  • Butyrophilin (BTN) family interactions
CLUAP1 clusterin associated protein 1
  • Intraflagellar transport
  • Intraflagellar transport
CYP2E1 cytochrome P450 family 2 subfamily E member 1
  • Xenobiotics
  • CYP2E1 reactions
  • Biosynthesis of maresin-like SPMs
  • Diacerein
DISC1 DISC1 scaffold protein
ELN elastin
  • Degradation of the extracellular matrix
  • Elastic fibre formation
  • Molecules associated with elastic fibres
  • Molecules associated with elastic fibres
  • Rofecoxib
  • Congenital supravalvar aortic stenosis
  • Cutis laxa, including: Autosomal dominant cutis laxa (ADCL); Autosomal recessive cutis laxa I (ARCL1); Autosomal recessive cutis laxa II (ARCL2); X-linked recessive cutis laxa (XRCL); Wrinkly skin syndrome
EPPIN epididymal peptidase inhibitor
  • Antimicrobial peptides
FOS Fos proto-oncogene, AP-1 transcription factor subunit
  • Oxidative Stress Induced Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • FCERI mediated MAPK activation
  • Activation of the AP-1 family of transcription factors
  • Interleukin-4 and Interleukin-13 signaling
  • TP53 Regulates Transcription of DNA Repair Genes
  • Estrogen-dependent gene expression
  • NGF-stimulated transcription
  • NGF-stimulated transcription
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Pseudoephedrine
  • Nadroparin
GRB2 growth factor receptor bound protein 2
  • Interleukin-15 signaling
  • Interleukin-15 signaling
  • STAT5 activation downstream of FLT3 ITD mutants
  • Signaling by FLT3 ITD and TKD mutants
  • Signaling by FLT3 ITD and TKD mutants
  • Pegademase
  • 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid

Page 1 out of 3 pages